Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0002012383-26-000643·ArriVent BioPharma, Inc.
Schedule 13G ownership disclosure
ArriVent Biopharma Inc
Common Stock · CUSIP: 04272N102
Event date: 2025-12-31
- Filing-level shares
- 2,319,341
- Percent of class
- 5.6%
- BlackRock, Inc.
Shares: 2,319,341 · Class: 5.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-26-000643
- Form type
- SCHEDULE 13G
- Filer
- ArriVent BioPharma, Inc.
- CIK
- CIK 1868279
- Filed
- Jan 21, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership